Fraunhofer Institute for Molecular Biology and Applied Ecology IME

Welcome to the Fraunhofer IME. We conduct research in the field of applied life sciences from a molecular level to entire ecosystems and are your partner for contract research in the areas of pharmacy, medicine, chemistry, agriculture, as well as environmental and consumer protection. Our research and development portfolio is focused on industry, small and medium enterprises and on the public sector.

The overarching goal of our research activities at Fraunhofer IME is the development and use of novel technologies for diagnosis and therapy of human and animal diseases as well as the protection of crop plants and food sources.

The Fraunhofer IME presented a living exhibit and its digital twin at the joint Fraunhofer booth “Future Factory” at the Hanover Trade Fair 2018.

The living exhibit attracted many visitors at the Hanover Trade Fair from 23rd to 27th April. For most, the use of plants to produce protein-based pharmaceuticals was new territory. Fraunhofer IME is one of the pioneers in research on „Plant-made Pharmaceuticals“ in Germany. Plant biotechnologists transform plants into protein factories whose cells produce the desired proteins - simply, quickly and safely.

We invite to the Final Conference of “NanoGRAVUR“, a joint project funded by the Federal Ministry of Education and Research.

May 3^rd: Final conference "Scientific achievements and regulatory needs for "grouping" of nanomaterials."
Target Group: (Young) scientists, experienced regulators, users

May 4^th:  Workshop "Dissemination: Applicability and implementation of the 'nanoGRAVUR' concepts" under participation of Fraunhofer IME. Target Group: Public bodies, Ministries and Industry (in German)

Human stem cells, which can be produced from mature cells by dialing back their developmental programming - so-called "induced pluripotent stem cells (iPS cells)" - have enormous potential for regenerative medicine as well as for the research and development of new therapeutics. To ensure the development of better drug candidates in the field of patient-derived iPS cells, Evotec AG and the Fraunhofer Institute for Molecular Biology and Applied Ecology IME are entering into a strategic alliance.

On July 5, the 4th Annual G20 World Brain Mapping Summit / Neuroscience-20 will take place in Hamburg.

The aim of the Summit is to further develop activities in neuroscientific research projects to map the human brain and to unite the best scientists, engineers, doctors and surgeons worldwide in the fight against neurological disorders.